ABC News
· May 11, 2025 10:22 PM EDT
Not market news
Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs
A new study shows that people Zepbound lost about 50% more weight than those using Wegovy
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
